Showing results (221-230 of 290) with videos related to
Sort By:
Pageof 29
Journal of the American Society of Nephrology : JASN|January 22, 2022
Combined Kelch-like 3 and Cullin 3 Degradation is a Central Mechanism in Familial Hyperkalemic Hypertension in MiceYujiro Maeoka, Mohammed Z Ferdaus, Ryan J Cornelius, et al.Nature Medicine|October 4, 2011
The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertensionEwout J Hoorn, Stephen B Walsh, James A McCormick, et al.International Archives of Occupational and Environmental Health|January 27, 2022
Association between secondhand smoke and peripheral arterial disease: a meta-analysis of cross-sectional studiesChih-Wei Wu, Hung-Yi Chuang, Kazuhiro Watanabe, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|August 27, 2011
Cdkn2a is an atherosclerosis modifier locus that regulates monocyte/macrophage proliferationChao-Ling Kuo, Andrew J Murphy, Scott Sayers, et al.Journal of Pharmaceutical and Biomedical Analysis|July 12, 2016
Serum metabonomics study of the hepatoprotective effect of Corydalis saxicola Bunting on carbon tetrachloride-induced acute hepatotoxicity in rats by (1)H NMR analysisYong-Hong Liang, Chao-Ling Tang, Shi-Yin Lu, et al.Acta Biomaterialia|January 23, 2017
Sphingosine-1-phosphate improves endothelialization with reduction of thrombosis in recellularized human umbilical vein graft by inhibiting syndecan-1 shedding in vitroKai Hsia, Ming-Jie Yang, Wei-Min Chen, et al.Frontiers in Immunology|May 5, 2023
Case Report: Blinatumomab therapy for the treatment of B-cell acute lymphoblastic leukemia patients with central nervous system infiltrationHan-Yu Cao, Hui Chen, Song-Bai Liu, et al.Annals of Hematology|December 12, 2024
Chidamide combined with azacitidine as a novel double epigenetic preemptive treatment for a myelodysplastic syndrome patient showing molecular relapse after allogeneic hematopoietic stem cell transplantationFang-Tong Liu, Chao-Ling Wan, Yuan-Hong Huang, et al.Annals of Hematology|April 27, 2023
Rapid molecular response to dasatinib in Ph-like acute lymphoblastic leukemia patients with ABL1 rearrangements: case series and literature reviewKai-Wen Tan, Yi-Yan Zhu, Qiao-Cheng Qiu, et al.Clinical Case Reports|December 12, 2023
Preemptive inotuzumab ozogamicin eradicated measurable residual disease in Ph-negative acute lymphoblastic leukemia relapsed post CD19 CART therapySi-Man Huang, Chao-Ling Wan, Han-Yu Cao, et al.Pageof 29